RSS

Archive | Actos RSS feed for this section

Actos lawsuit settlement for $2.2 Billion

1. April 2015

Comments Off on Actos lawsuit settlement for $2.2 Billion

Takeda Pharmaceutical Co. has offered to pay more than $2.2 billion to resolve claims of hiding its Actos diabetes medicine’s cancer risks in what would be one of the largest U.S. settlements of patient lawsuits targeting drugs or devices. Takeda propose to settle more than 8,000 lawsuits in federal and state courts in the U.S. […]

Continue reading...

Bladder Cancer in Actos users

9. January 2012

0 Comments

Diabetes drug Actos has been linked to high risk of bladder cancer and other injuries. Recent medical studies confirm that Actos can cause bladder cancer and other injuries. Actos (pioglitazone) is a Type 2 diabetes drug often prescribed as an alternative to Avandia. At one time it was believed that Actos was safer. Actos lawsuits against Takeda […]

Continue reading...

Actos Active Ingredient

17. November 2011

0 Comments

Actos  is a Type 2 diabetes drug which has been linked to an increased risk of heart attack, congestive heart failure, heart disease and death. It has also been linked to an increased risk of bladder cancer, rhabdomyolysis (kidney damage), liver damage, and bone fracture. Here is an updated list of drugs with active ingredient […]

Continue reading...

Actos Bladder Cancer Lawsuit

3. November 2011

0 Comments

The Diabetes drug Actos has been linked to high risk of bladder cancer and other injuries. Common Symptops: Dark urine Frequent urination Painful urination Urinary tract infection Drugs effected Generic name: Pioglitazone Actos ACTOplus met ACTOplus met XR duetact NDC numbers found on Actos packaging: 00247-1924-30 00247-1925-30 00247-1926-30 12280-0060-30 13411-0101-03 13411-0102-03 13411-0103-03 21695-0147-15 21695-0148-15 49999-0450-30 49999-0451-30 54569-4880-00 […]

Continue reading...